About Eurozyto
Eurozyto GmbH is a pharmaceutical manufacturing company according to §13 AMG with a focus on innovative forms of care. Infusion solutions for parenteral nutrition, enzyme replacement therapy or chemotherapy, for example, are produced in Eurozyto's clean rooms. In addition to the pharmaceutical specialty wholesaler Pharventia GmbH, the Eurozyto group of companies also includes Ligetis GmbH, a company that manages patient care and ensures it via cooperation partners.
Within Eurozyto GmbH itself, a separate research and development department has been set up to look for opportunities for advanced forms of care. One result of this department is the Eurotube, a new type of infusion bag for parenteral nutrition which, in addition to the usual 1 - 3 chambers for macronutrients, also contains a so-called 6-chamber therapy block in which fat- and water-soluble vitamins, trace elements, electrolytes and other medications can be contained. This gives the doctor additional options for treating the patient at home. With the Eurotube, micronutrients such as vitamins and trace elements in particular are already added to the therapy block at the manufacturing plant, so that it is generally no longer necessary to inject these components into the infusion bag at the patient's home.
In 2017, Eurozyto GmbH was the only company to reach the final of the Hessen Champions innovation and growth award of the state of Hessen in two categories - innovation and job engine.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
Advertisement
